nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R2—forebrain—schizophrenia	0.0176	0.0648	CbGeAlD
Isoprenaline—ADRBK1—blood plasma—schizophrenia	0.0129	0.0474	CbGeAlD
Isoprenaline—MAPK1—blood plasma—schizophrenia	0.0127	0.0467	CbGeAlD
Isoprenaline—PIK3R3—telencephalon—schizophrenia	0.011	0.0404	CbGeAlD
Isoprenaline—PIK3R2—endocrine gland—schizophrenia	0.0102	0.0376	CbGeAlD
Isoprenaline—PIK3R2—nervous system—schizophrenia	0.00953	0.0352	CbGeAlD
Isoprenaline—PIK3R1—telencephalon—schizophrenia	0.00936	0.0345	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—schizophrenia	0.00918	0.0339	CbGeAlD
Isoprenaline—PIK3R3—gonad—schizophrenia	0.00914	0.0337	CbGeAlD
Isoprenaline—PIK3R2—cerebellum—schizophrenia	0.00897	0.0331	CbGeAlD
Isoprenaline—PIK3R2—brain—schizophrenia	0.00729	0.0269	CbGeAlD
Isoprenaline—ADRBK1—forebrain—schizophrenia	0.00704	0.026	CbGeAlD
Isoprenaline—MAPK1—forebrain—schizophrenia	0.00694	0.0256	CbGeAlD
Isoprenaline—PIK3R3—endocrine gland—schizophrenia	0.00691	0.0255	CbGeAlD
Isoprenaline—PIK3R1—blood—schizophrenia	0.00681	0.0251	CbGeAlD
Isoprenaline—PIK3R1—midbrain—schizophrenia	0.00672	0.0248	CbGeAlD
Isoprenaline—ADRBK1—telencephalon—schizophrenia	0.00647	0.0239	CbGeAlD
Isoprenaline—PIK3R3—nervous system—schizophrenia	0.00647	0.0239	CbGeAlD
Isoprenaline—MAPK1—telencephalon—schizophrenia	0.00638	0.0235	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—schizophrenia	0.00623	0.023	CbGeAlD
Isoprenaline—PIK3R3—cerebellum—schizophrenia	0.00609	0.0225	CbGeAlD
Isoprenaline—ADRBK1—gonad—schizophrenia	0.0054	0.0199	CbGeAlD
Isoprenaline—MAPK1—gonad—schizophrenia	0.00533	0.0196	CbGeAlD
Isoprenaline—PIK3R1—cerebellum—schizophrenia	0.0052	0.0192	CbGeAlD
Isoprenaline—PIK3R3—brain—schizophrenia	0.00494	0.0182	CbGeAlD
Isoprenaline—ADRBK1—blood—schizophrenia	0.00471	0.0174	CbGeAlD
Isoprenaline—MAPK1—blood—schizophrenia	0.00464	0.0171	CbGeAlD
Isoprenaline—PIK3R1—brain—schizophrenia	0.00422	0.0156	CbGeAlD
Isoprenaline—ADRBK1—endocrine gland—schizophrenia	0.00408	0.0151	CbGeAlD
Isoprenaline—MAPK1—endocrine gland—schizophrenia	0.00402	0.0148	CbGeAlD
Isoprenaline—ADRBK1—nervous system—schizophrenia	0.00382	0.0141	CbGeAlD
Isoprenaline—MAPK1—nervous system—schizophrenia	0.00377	0.0139	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—schizophrenia	0.00368	0.0136	CbGeAlD
Isoprenaline—MAPK1—central nervous system—schizophrenia	0.00363	0.0134	CbGeAlD
Isoprenaline—ADRBK1—cerebellum—schizophrenia	0.0036	0.0133	CbGeAlD
Isoprenaline—MAPK1—cerebellum—schizophrenia	0.00355	0.0131	CbGeAlD
Isoprenaline—ADRB1—forebrain—schizophrenia	0.00295	0.0109	CbGeAlD
Isoprenaline—ADRBK1—brain—schizophrenia	0.00292	0.0108	CbGeAlD
Isoprenaline—MAPK1—brain—schizophrenia	0.00288	0.0106	CbGeAlD
Isoprenaline—ADRB1—telencephalon—schizophrenia	0.00271	0.00999	CbGeAlD
Isoprenaline—ADRB1—endocrine gland—schizophrenia	0.00171	0.0063	CbGeAlD
Isoprenaline—ADRB1—nervous system—schizophrenia	0.0016	0.0059	CbGeAlD
Isoprenaline—Methyldopa—COMT—schizophrenia	0.00155	0.0865	CrCbGaD
Isoprenaline—ADRB1—central nervous system—schizophrenia	0.00154	0.00568	CbGeAlD
Isoprenaline—Norepinephrine—SLC18A2—schizophrenia	0.00128	0.0712	CrCbGaD
Isoprenaline—CYP1A1—blood—schizophrenia	0.00127	0.00469	CbGeAlD
Isoprenaline—ADRB1—brain—schizophrenia	0.00122	0.00451	CbGeAlD
Isoprenaline—Phenylephrine—MAOA—schizophrenia	0.0012	0.0669	CrCbGaD
Isoprenaline—CYP1A1—endocrine gland—schizophrenia	0.0011	0.00407	CbGeAlD
Isoprenaline—CYP1A1—nervous system—schizophrenia	0.00103	0.00381	CbGeAlD
Isoprenaline—CYP1A1—central nervous system—schizophrenia	0.000993	0.00366	CbGeAlD
Isoprenaline—Pindolol—HTR1B—schizophrenia	0.000825	0.0461	CrCbGaD
Isoprenaline—CYP1A1—brain—schizophrenia	0.000788	0.00291	CbGeAlD
Isoprenaline—Dopamine—COMT—schizophrenia	0.000757	0.0422	CrCbGaD
Isoprenaline—Phenylephrine—CYP1A2—schizophrenia	0.000704	0.0393	CrCbGaD
Isoprenaline—L-DOPA—DRD4—schizophrenia	0.00066	0.0368	CrCbGaD
Isoprenaline—Pindolol—HTR1A—schizophrenia	0.000653	0.0365	CrCbGaD
Isoprenaline—Dopamine—DRD4—schizophrenia	0.000613	0.0342	CrCbGaD
Isoprenaline—Dopamine—MAOA—schizophrenia	0.000571	0.0319	CrCbGaD
Isoprenaline—L-DOPA—DRD3—schizophrenia	0.000569	0.0318	CrCbGaD
Isoprenaline—Dopamine—HTR7—schizophrenia	0.000563	0.0314	CrCbGaD
Isoprenaline—Arformoterol—CYP2D6—schizophrenia	0.000559	0.0312	CrCbGaD
Isoprenaline—Formoterol—CYP2D6—schizophrenia	0.000559	0.0312	CrCbGaD
Isoprenaline—L-DOPA—DRD1—schizophrenia	0.000558	0.0312	CrCbGaD
Isoprenaline—Dopamine—DRD3—schizophrenia	0.000529	0.0295	CrCbGaD
Isoprenaline—Dopamine—DRD1—schizophrenia	0.000519	0.029	CrCbGaD
Isoprenaline—Dopamine—SLC6A3—schizophrenia	0.000492	0.0275	CrCbGaD
Isoprenaline—Epinephrine—TNF—schizophrenia	0.000446	0.0249	CrCbGaD
Isoprenaline—Dopamine—HTR1A—schizophrenia	0.000431	0.0241	CrCbGaD
Isoprenaline—Labetalol—CYP2D6—schizophrenia	0.000408	0.0228	CrCbGaD
Isoprenaline—L-DOPA—DRD2—schizophrenia	0.000394	0.022	CrCbGaD
Isoprenaline—Norepinephrine—DRD2—schizophrenia	0.000394	0.022	CrCbGaD
Isoprenaline—Pindolol—CYP2D6—schizophrenia	0.000392	0.0219	CrCbGaD
Isoprenaline—Dopamine—SLC6A4—schizophrenia	0.000368	0.0205	CrCbGaD
Isoprenaline—Dopamine—DRD2—schizophrenia	0.000366	0.0204	CrCbGaD
Isoprenaline—Norepinephrine—CYP1A2—schizophrenia	0.00036	0.0201	CrCbGaD
Isoprenaline—Dopamine—CYP1A2—schizophrenia	0.000335	0.0187	CrCbGaD
Isoprenaline—Epinephrine—CYP1A2—schizophrenia	0.000327	0.0183	CrCbGaD
Isoprenaline—L-DOPA—CYP2D6—schizophrenia	0.000278	0.0155	CrCbGaD
Isoprenaline—Dopamine—CYP2D6—schizophrenia	0.000259	0.0144	CrCbGaD
Isoprenaline—PIK3R2—Hemostasis—AKT1—schizophrenia	2.38e-05	3.34e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCKAR—schizophrenia	2.37e-05	3.33e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MEF2C—schizophrenia	2.36e-05	3.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PDE4B—schizophrenia	2.36e-05	3.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HTR2A—schizophrenia	2.35e-05	3.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—GSK3B—schizophrenia	2.34e-05	3.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—APOE—schizophrenia	2.34e-05	3.29e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR1A—schizophrenia	2.34e-05	3.29e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	2.33e-05	3.28e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PRKD1—schizophrenia	2.33e-05	3.27e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCKAR—schizophrenia	2.32e-05	3.26e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—APOA1—schizophrenia	2.31e-05	3.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1B—schizophrenia	2.31e-05	3.24e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—APOE—schizophrenia	2.3e-05	3.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PLA2G4A—schizophrenia	2.3e-05	3.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NPS—schizophrenia	2.3e-05	3.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADORA2A—schizophrenia	2.3e-05	3.23e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—EP300—schizophrenia	2.29e-05	3.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—schizophrenia	2.28e-05	3.21e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—APOA1—schizophrenia	2.28e-05	3.2e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—YWHAZ—schizophrenia	2.28e-05	3.2e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1B—schizophrenia	2.27e-05	3.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—APOE—schizophrenia	2.27e-05	3.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NRG1—schizophrenia	2.26e-05	3.18e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PLA2G4A—schizophrenia	2.26e-05	3.18e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2C—schizophrenia	2.26e-05	3.18e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD1—schizophrenia	2.26e-05	3.18e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PLA2G4A—schizophrenia	2.25e-05	3.16e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADORA2A—schizophrenia	2.25e-05	3.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MEF2C—schizophrenia	2.24e-05	3.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—APOA1—schizophrenia	2.24e-05	3.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ESR1—schizophrenia	2.23e-05	3.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERBB3—schizophrenia	2.23e-05	3.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PLA2G4A—schizophrenia	2.21e-05	3.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—EP300—schizophrenia	2.21e-05	3.11e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NRG1—schizophrenia	2.21e-05	3.1e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FGA—schizophrenia	2.2e-05	3.1e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—HTR2A—schizophrenia	2.2e-05	3.1e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ESR1—schizophrenia	2.2e-05	3.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NTRK2—schizophrenia	2.2e-05	3.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NRG1—schizophrenia	2.2e-05	3.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD3—schizophrenia	2.19e-05	3.08e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MEF2C—schizophrenia	2.19e-05	3.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—YWHAZ—schizophrenia	2.17e-05	3.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—EP300—schizophrenia	2.17e-05	3.05e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FGA—schizophrenia	2.15e-05	3.03e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—HTR2A—schizophrenia	2.15e-05	3.03e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ATP2A2—schizophrenia	2.15e-05	3.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOTCH4—schizophrenia	2.15e-05	3.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NPY—schizophrenia	2.15e-05	3.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—AKT1—schizophrenia	2.14e-05	3.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD4—schizophrenia	2.12e-05	2.99e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ERBB3—schizophrenia	2.12e-05	2.98e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—YWHAZ—schizophrenia	2.11e-05	2.97e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—AKT1—schizophrenia	2.11e-05	2.96e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—YWHAZ—schizophrenia	2.1e-05	2.96e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NPY—schizophrenia	2.1e-05	2.95e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOTCH4—schizophrenia	2.1e-05	2.95e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ATP2A2—schizophrenia	2.1e-05	2.95e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—OXT—schizophrenia	2.07e-05	2.91e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR1B—schizophrenia	2.07e-05	2.91e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ERBB3—schizophrenia	2.07e-05	2.91e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—AKT1—schizophrenia	2.07e-05	2.91e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—EP300—schizophrenia	2.06e-05	2.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ERBB3—schizophrenia	2.06e-05	2.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—AKT1—schizophrenia	2.05e-05	2.89e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—EP300—schizophrenia	2.04e-05	2.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HTR2A—schizophrenia	2.04e-05	2.87e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—EP300—schizophrenia	2.03e-05	2.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CNR1—schizophrenia	2.03e-05	2.85e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR1B—schizophrenia	2.03e-05	2.85e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—OXT—schizophrenia	2.03e-05	2.85e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—GSK3B—schizophrenia	2.03e-05	2.85e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—EP300—schizophrenia	2e-05	2.81e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HTR2A—schizophrenia	2e-05	2.81e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—GSK3B—schizophrenia	2e-05	2.81e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR1A—schizophrenia	1.99e-05	2.8e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HTR2A—schizophrenia	1.99e-05	2.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR7—schizophrenia	1.98e-05	2.78e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—DRD2—schizophrenia	1.98e-05	2.78e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MTHFR—schizophrenia	1.98e-05	2.78e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NPS—schizophrenia	1.96e-05	2.76e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HTR2A—schizophrenia	1.96e-05	2.75e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR1A—schizophrenia	1.95e-05	2.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—EP300—schizophrenia	1.95e-05	2.74e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GAPDH—schizophrenia	1.94e-05	2.73e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD1—schizophrenia	1.93e-05	2.71e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2C—schizophrenia	1.93e-05	2.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—AKT1—schizophrenia	1.93e-05	2.71e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CLOCK—schizophrenia	1.92e-05	2.71e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NPS—schizophrenia	1.92e-05	2.7e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.92e-05	2.7e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—EP300—schizophrenia	1.9e-05	2.68e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.9e-05	2.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—APOE—schizophrenia	1.9e-05	2.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—AKT1—schizophrenia	1.88e-05	2.65e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD1—schizophrenia	1.88e-05	2.65e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2C—schizophrenia	1.88e-05	2.65e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—EP300—schizophrenia	1.88e-05	2.64e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TPH2—schizophrenia	1.87e-05	2.64e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CACNB2—schizophrenia	1.87e-05	2.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—APOA1—schizophrenia	1.87e-05	2.64e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NTRK2—schizophrenia	1.87e-05	2.63e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1B—schizophrenia	1.87e-05	2.63e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PRL—schizophrenia	1.87e-05	2.63e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD3—schizophrenia	1.86e-05	2.62e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—APOE—schizophrenia	1.85e-05	2.6e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—DPYD—schizophrenia	1.84e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—APOE—schizophrenia	1.84e-05	2.59e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NTRK2—schizophrenia	1.83e-05	2.58e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—APOA1—schizophrenia	1.83e-05	2.57e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD3—schizophrenia	1.82e-05	2.57e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—APOA1—schizophrenia	1.82e-05	2.56e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD4—schizophrenia	1.81e-05	2.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ESR1—schizophrenia	1.81e-05	2.55e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—schizophrenia	1.79e-05	2.52e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD4—schizophrenia	1.77e-05	2.49e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ESR1—schizophrenia	1.77e-05	2.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—S100B—schizophrenia	1.74e-05	2.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—AKT1—schizophrenia	1.73e-05	2.44e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CNR1—schizophrenia	1.73e-05	2.43e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—GSK3B—schizophrenia	1.73e-05	2.43e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—FOS—schizophrenia	1.71e-05	2.41e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CACNA1C—schizophrenia	1.71e-05	2.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—AKT1—schizophrenia	1.71e-05	2.41e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CNR1—schizophrenia	1.69e-05	2.38e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—DRD2—schizophrenia	1.69e-05	2.37e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR7—schizophrenia	1.69e-05	2.37e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EP300—schizophrenia	1.67e-05	2.35e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3C2A—schizophrenia	1.67e-05	2.35e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—EP300—schizophrenia	1.67e-05	2.35e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB4—schizophrenia	1.67e-05	2.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—AKT1—schizophrenia	1.66e-05	2.34e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—DRD2—schizophrenia	1.65e-05	2.32e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR7—schizophrenia	1.65e-05	2.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—GSK3B—schizophrenia	1.64e-05	2.31e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—GSK3B—schizophrenia	1.6e-05	2.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—EP300—schizophrenia	1.59e-05	2.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—GSK3B—schizophrenia	1.59e-05	2.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRL—schizophrenia	1.59e-05	2.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PLA2G4A—schizophrenia	1.57e-05	2.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—AKT1—schizophrenia	1.56e-05	2.2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRL—schizophrenia	1.56e-05	2.19e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—schizophrenia	1.55e-05	2.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—EP300—schizophrenia	1.54e-05	2.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NRG1—schizophrenia	1.54e-05	2.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MEF2C—schizophrenia	1.52e-05	2.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—AKT1—schizophrenia	1.5e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP2D6—schizophrenia	1.5e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SNAP25—schizophrenia	1.5e-05	2.11e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—S100B—schizophrenia	1.48e-05	2.09e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—AKT1—schizophrenia	1.48e-05	2.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—YWHAZ—schizophrenia	1.47e-05	2.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—schizophrenia	1.46e-05	2.06e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—S100B—schizophrenia	1.45e-05	2.04e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—AKT1—schizophrenia	1.44e-05	2.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB3—schizophrenia	1.44e-05	2.03e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB4—schizophrenia	1.42e-05	2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB4—schizophrenia	1.39e-05	1.95e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HTR2A—schizophrenia	1.39e-05	1.95e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—AKT1—schizophrenia	1.36e-05	1.92e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP1A2—schizophrenia	1.36e-05	1.91e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—schizophrenia	1.34e-05	1.89e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TH—schizophrenia	1.34e-05	1.88e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PLA2G4A—schizophrenia	1.33e-05	1.88e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—schizophrenia	1.33e-05	1.88e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EP300—schizophrenia	1.33e-05	1.87e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EP300—schizophrenia	1.31e-05	1.85e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NRG1—schizophrenia	1.31e-05	1.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—schizophrenia	1.31e-05	1.84e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PLA2G4A—schizophrenia	1.31e-05	1.84e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MEF2C—schizophrenia	1.3e-05	1.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—EP300—schizophrenia	1.29e-05	1.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—schizophrenia	1.29e-05	1.81e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NRG1—schizophrenia	1.28e-05	1.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOA1—schizophrenia	1.27e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—schizophrenia	1.27e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MEF2C—schizophrenia	1.27e-05	1.79e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—YWHAZ—schizophrenia	1.25e-05	1.76e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—schizophrenia	1.25e-05	1.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ESR1—schizophrenia	1.23e-05	1.73e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—YWHAZ—schizophrenia	1.23e-05	1.73e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—schizophrenia	1.23e-05	1.73e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB3—schizophrenia	1.23e-05	1.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—schizophrenia	1.22e-05	1.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—schizophrenia	1.21e-05	1.7e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB3—schizophrenia	1.2e-05	1.69e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—schizophrenia	1.2e-05	1.68e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—schizophrenia	1.19e-05	1.67e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HTR2A—schizophrenia	1.18e-05	1.66e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—schizophrenia	1.18e-05	1.66e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HTR2A—schizophrenia	1.16e-05	1.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—schizophrenia	1.15e-05	1.62e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—COMT—schizophrenia	1.14e-05	1.6e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EP300—schizophrenia	1.14e-05	1.6e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—schizophrenia	1.13e-05	1.59e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTP1—schizophrenia	1.13e-05	1.59e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MAOA—schizophrenia	1.13e-05	1.59e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GSK3B—schizophrenia	1.12e-05	1.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—schizophrenia	1.1e-05	1.55e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—schizophrenia	1.1e-05	1.54e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.09e-05	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOA1—schizophrenia	1.09e-05	1.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EP300—schizophrenia	1.08e-05	1.52e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—schizophrenia	1.08e-05	1.52e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—schizophrenia	1.07e-05	1.51e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCB1—schizophrenia	1.07e-05	1.5e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOA1—schizophrenia	1.06e-05	1.49e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EP300—schizophrenia	1.05e-05	1.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EP300—schizophrenia	1.05e-05	1.47e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ESR1—schizophrenia	1.05e-05	1.47e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PLA2G4A—schizophrenia	1.04e-05	1.46e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTM1—schizophrenia	1.04e-05	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ESR1—schizophrenia	1.03e-05	1.44e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—schizophrenia	1.01e-05	1.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—schizophrenia	1.01e-05	1.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—schizophrenia	9.63e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—schizophrenia	9.54e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GSK3B—schizophrenia	9.51e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—schizophrenia	9.4e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—schizophrenia	9.32e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GSK3B—schizophrenia	9.3e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—schizophrenia	9.18e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—schizophrenia	8.55e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOA1—schizophrenia	8.45e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—schizophrenia	8.06e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—schizophrenia	7.94e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—schizophrenia	7.81e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—schizophrenia	7.73e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—schizophrenia	7.54e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—schizophrenia	7.51e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EP300—schizophrenia	7.34e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—schizophrenia	7.05e-06	9.91e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	6.9e-06	9.7e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—schizophrenia	6.86e-06	9.65e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—schizophrenia	6.53e-06	9.18e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—schizophrenia	6.4e-06	9e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—schizophrenia	6.37e-06	8.96e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—schizophrenia	6.34e-06	8.91e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—schizophrenia	6.26e-06	8.81e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EP300—schizophrenia	6.26e-06	8.8e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EP300—schizophrenia	6.12e-06	8.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—schizophrenia	5.25e-06	7.39e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—EP300—schizophrenia	4.87e-06	6.85e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—schizophrenia	4.48e-06	6.3e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—schizophrenia	4.44e-06	6.24e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—schizophrenia	4.38e-06	6.16e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—schizophrenia	3.78e-06	5.32e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—schizophrenia	3.7e-06	5.2e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—schizophrenia	2.94e-06	4.14e-06	CbGpPWpGaD
